139 related articles for article (PubMed ID: 22714912)
1. Stem cell gene Girdin: a potential early liver metastasis predictor of colorectal cancer.
Liu C; Xue H; Lu Y; Chi B
Mol Biol Rep; 2012 Sep; 39(9):8717-22. PubMed ID: 22714912
[TBL] [Abstract][Full Text] [Related]
2. Girdin protein: a new potential distant metastasis predictor of breast cancer.
Liu C; Zhang Y; Xu H; Zhang R; Li H; Lu P; Jin F
Med Oncol; 2012 Sep; 29(3):1554-60. PubMed ID: 22116776
[TBL] [Abstract][Full Text] [Related]
3. Expression of girdin in human colorectal cancer and its association with tumor progression.
Jun BY; Kim SW; Jung CK; Cho YK; Lee IS; Choi MG; Choi KY; Oh ST
Dis Colon Rectum; 2013 Jan; 56(1):51-7. PubMed ID: 23222280
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of Girdin protein expression in glioma.
Zhao L; Ma S; Liu Q; Liang P
ScientificWorldJournal; 2013; 2013():986073. PubMed ID: 24288520
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of AEG-1 in liver metastasis of colorectal cancer.
Jiang T; Zhu A; Zhu Y; Piao D
Med Oncol; 2012 Dec; 29(4):2858-63. PubMed ID: 22351252
[TBL] [Abstract][Full Text] [Related]
6. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
7. Nanog: a potential biomarker for liver metastasis of colorectal cancer.
Xu F; Dai C; Zhang R; Zhao Y; Peng S; Jia C
Dig Dis Sci; 2012 Sep; 57(9):2340-6. PubMed ID: 22562535
[TBL] [Abstract][Full Text] [Related]
8. CD146 protein as a marker to predict postoperative liver metastasis in colorectal cancer.
Tian B; Zhang Y; Li N
Cancer Biother Radiopharm; 2013; 28(6):466-70. PubMed ID: 23745687
[TBL] [Abstract][Full Text] [Related]
9. Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.
Garcia-Marcos M; Jung BH; Ear J; Cabrera B; Carethers JM; Ghosh P
FASEB J; 2011 Feb; 25(2):590-9. PubMed ID: 20974669
[TBL] [Abstract][Full Text] [Related]
10. Silencing of Girdin suppresses the malignant behavior of colorectal carcinoma cells.
Lu J; Zhang L; Zhou H; Du Z; Zhang G
Oncol Rep; 2018 Aug; 40(2):887-894. PubMed ID: 29989653
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin.
Zhang YJ; Li AJ; Han Y; Yin L; Lin MB
World J Gastroenterol; 2014 Jul; 20(25):8229-36. PubMed ID: 25009397
[TBL] [Abstract][Full Text] [Related]
12. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
[TBL] [Abstract][Full Text] [Related]
13. MiR-328-3p inhibits cell proliferation and metastasis in colorectal cancer by targeting Girdin and inhibiting the PI3K/Akt signaling pathway.
Pan S; Ren F; Li L; Liu D; Li Y; Wang A; Li W; Dong Y; Guo W
Exp Cell Res; 2020 May; 390(1):111939. PubMed ID: 32142853
[TBL] [Abstract][Full Text] [Related]
14. Talen-mediated girdin knockout downregulates cell proliferation, migration and invasion in human esophageal carcinoma ECA109 cells.
Cao K; Jiang W; Cao P; Zou Q; Xiao S; Zhou J; Huang C
Mol Med Rep; 2014 Aug; 10(2):848-54. PubMed ID: 24865549
[TBL] [Abstract][Full Text] [Related]
15. Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer.
Zong Z; Zhou T; Rao L; Jiang Z; Li Y; Hou Z; Yang B; Han F; Chen S
Cancer Med; 2016 Apr; 5(4):623-30. PubMed ID: 26775684
[TBL] [Abstract][Full Text] [Related]
16. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
[No Abstract] [Full Text] [Related]
17. Girdin protein expression is associated with poor prognosis in patients with invasive breast cancer.
Choi JS; Kim KH; Oh E; Shin YK; Seo J; Kim SH; Park S; Choi YL
Pathology; 2017 Oct; 49(6):618-626. PubMed ID: 28818465
[TBL] [Abstract][Full Text] [Related]
18. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 as a novel predictive biomarker for metastasis and poor prognosis in colorectal cancer.
Gao Y; Li C; Nie M; Lu Y; Lin S; Yuan P; Sun X
Tumour Biol; 2014 May; 35(5):4171-5. PubMed ID: 24395653
[TBL] [Abstract][Full Text] [Related]
20. Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer.
Michl M; Taverna F; Kumbrink J; Schiergens TS; Heinemann V; Engel J; Kirchner T; Neumann J
Virchows Arch; 2021 Apr; 478(4):695-705. PubMed ID: 33300106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
